Copyright Reports & Markets. All rights reserved.

Global Open-Angle Glaucoma Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Prostaglandin Analogs (PGAs)
      • 1.4.3 Combination of PGAs
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Open-Angle Glaucoma Therapeutics Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Research Institute
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Open-Angle Glaucoma Therapeutics Market Size
    • 2.2 Open-Angle Glaucoma Therapeutics Growth Trends by Regions
      • 2.2.1 Open-Angle Glaucoma Therapeutics Market Size by Regions (2019-2025)
      • 2.2.2 Open-Angle Glaucoma Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Open-Angle Glaucoma Therapeutics Market Size by by Players
      • 3.1.1 Global Open-Angle Glaucoma Therapeutics Revenue by by Players (2014-2019)
      • 3.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Open-Angle Glaucoma Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Open-Angle Glaucoma Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Open-Angle Glaucoma Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Open-Angle Glaucoma Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Open-Angle Glaucoma Therapeutics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Open-Angle Glaucoma Therapeutics Market Size (2014-2019)
    • 5.2 Open-Angle Glaucoma Therapeutics Key Players in North America
    • 5.3 North America Open-Angle Glaucoma Therapeutics Market Size by Type
    • 5.4 North America Open-Angle Glaucoma Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Open-Angle Glaucoma Therapeutics Market Size (2014-2019)
    • 6.2 Open-Angle Glaucoma Therapeutics Key Players in Europe
    • 6.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Type
    • 6.4 Europe Open-Angle Glaucoma Therapeutics Market Size by Application

    7 China

    • 7.1 China Open-Angle Glaucoma Therapeutics Market Size (2014-2019)
    • 7.2 Open-Angle Glaucoma Therapeutics Key Players in China
    • 7.3 China Open-Angle Glaucoma Therapeutics Market Size by Type
    • 7.4 China Open-Angle Glaucoma Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Open-Angle Glaucoma Therapeutics Market Size (2014-2019)
    • 8.2 Open-Angle Glaucoma Therapeutics Key Players in Japan
    • 8.3 Japan Open-Angle Glaucoma Therapeutics Market Size by Type
    • 8.4 Japan Open-Angle Glaucoma Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size (2014-2019)
    • 9.2 Open-Angle Glaucoma Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Type
    • 9.4 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Application

    10 India

    • 10.1 India Open-Angle Glaucoma Therapeutics Market Size (2014-2019)
    • 10.2 Open-Angle Glaucoma Therapeutics Key Players in India
    • 10.3 India Open-Angle Glaucoma Therapeutics Market Size by Type
    • 10.4 India Open-Angle Glaucoma Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Open-Angle Glaucoma Therapeutics Market Size (2014-2019)
    • 11.2 Open-Angle Glaucoma Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Open-Angle Glaucoma Therapeutics Market Size by Type
    • 11.4 Central & South America Open-Angle Glaucoma Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Aerie Pharmaceuticals Inc.
      • 12.1.1 Aerie Pharmaceuticals Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Open-Angle Glaucoma Therapeutics Introduction
      • 12.1.4 Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2014-2019))
      • 12.1.5 Aerie Pharmaceuticals Inc. Recent Development
    • 12.2 Allergan Plc
      • 12.2.1 Allergan Plc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Open-Angle Glaucoma Therapeutics Introduction
      • 12.2.4 Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2014-2019)
      • 12.2.5 Allergan Plc Recent Development
    • 12.3 Bausch Health Companies, Inc.
      • 12.3.1 Bausch Health Companies, Inc. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Open-Angle Glaucoma Therapeutics Introduction
      • 12.3.4 Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2014-2019)
      • 12.3.5 Bausch Health Companies, Inc. Recent Development
    • 12.4 Novartis AG
      • 12.4.1 Novartis AG Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Open-Angle Glaucoma Therapeutics Introduction
      • 12.4.4 Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2014-2019)
      • 12.4.5 Novartis AG Recent Development
    • 12.5 Pfizer Inc.
      • 12.5.1 Pfizer Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Open-Angle Glaucoma Therapeutics Introduction
      • 12.5.4 Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2014-2019)
      • 12.5.5 Pfizer Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss.
      The increasing demand for combination drugs will be one of the primary drivers of the open-angle glaucoma therapeutics market. Combination drugs have minimal adverse effects and help in overcoming the limitations of monotherapy. Combination drugs also help in improving tolerability by allowing the use of the two compounds below their dose thresholds.
      In 2018, the global Open-Angle Glaucoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Open-Angle Glaucoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Open-Angle Glaucoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Aerie Pharmaceuticals Inc.
      Allergan Plc
      Bausch Health Companies, Inc.
      Novartis AG
      Pfizer Inc.
      ...

      Market segment by Type, the product can be split into
      Prostaglandin Analogs (PGAs)
      Combination of PGAs
      Other

      Market segment by Application, split into
      Hospital
      Clinic
      Research Institute
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Open-Angle Glaucoma Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Open-Angle Glaucoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Open-Angle Glaucoma Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now